<DOC>
	<DOC>NCT02288845</DOC>
	<brief_summary>The purpose of this study is to determine the relationship between ITI-007 dose, plasma levels and brain receptor occupancy in patients with stable schizophrenia.</brief_summary>
	<brief_title>Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients with schizophrenia who are drugfree with regard to their antipsychotic medication In clinical remission and free from acute exacerbation of their psychosis In good health Clinically significant medical conditions considered inappropriate for trial participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>